,

Oskar Steinbrecher1, Thomas Brodowicz1, Petar Popov1

  • 1Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

In vivo (Athens, Greece)
|December 26, 2023
PubMed
概括

辅助性埃里布林在手术后对高风险脂肪肉瘤 (LPS) 患者显示有前途,这些患者不能容忍密集化疗. 这项研究在一小群患者中发现了可控的毒性和令人鼓舞的生存结果.